P D Hughes1. 1. John James Memorial Hospital, Canberra, Australian Capital Territory, Australia. hughes.p.urol@interact.net.au
Abstract
BACKGROUND: Since 1988 the author has used only endoscopic injection of Teflon (polytetrafluoroethylene) paste in the correction of ureteric reflux, in adults and children. METHODS: The present paper reports a series of 32 patients, 18 children and 14 adults, with 45 refluxing ureters so treated. Intra-operative cystogram was carried out and a second Teflon paste injection was given under the same anaesthetic where persistent reflux was demonstrated after the initial Teflon injection, to reduce the number of anaesthetics given. RESULTS: In those patients who consented to a delayed cystogram after the first injection of Teflon, there was a cure rate of 83.3% in children and 70% in adults from that first injection. CONCLUSION: Endoscopic retro-ureteric injection of Teflon paste is done as a day case under general anaesthesia and causes the patient no pain postoperatively. It gives a high cure rate and is an option that should be offered to every patient where a decision has been made to correct ureteric reflux.
BACKGROUND: Since 1988 the author has used only endoscopic injection of Teflon (polytetrafluoroethylene) paste in the correction of ureteric reflux, in adults and children. METHODS: The present paper reports a series of 32 patients, 18 children and 14 adults, with 45 refluxing ureters so treated. Intra-operative cystogram was carried out and a second Teflon paste injection was given under the same anaesthetic where persistent reflux was demonstrated after the initial Teflon injection, to reduce the number of anaesthetics given. RESULTS: In those patients who consented to a delayed cystogram after the first injection of Teflon, there was a cure rate of 83.3% in children and 70% in adults from that first injection. CONCLUSION: Endoscopic retro-ureteric injection of Teflon paste is done as a day case under general anaesthesia and causes the patient no pain postoperatively. It gives a high cure rate and is an option that should be offered to every patient where a decision has been made to correct ureteric reflux.